Browse by Speaker

Type here to filter the list

A
Ahluwalia, Manmeet

Cleveland Clinic
CTIM-12 - Randomized Phase 2 Study of Nivolumab (nivo) plus Either Standard or Reduced Dose Bevacizumab (bev) in Recurrent Glioblastoma (rGBM)
Manmeet Ahluwalia
Favorite
Akolkar, Dadasaheb

Datar Cancer Genetics
BIOM-35 - Multi Analyte Assay for Non-Invasive Diagnosis of Brain Tumors
Dadasaheb Akolkar
Favorite
Alonso, Marta M

Clinica Universidad de Navarra
CTIM-25 - Oncolytic virus for DIPG: The clinical experience with DNX-2401
Marta M Alonso
Favorite
IMMU-39 - TIM-3 aptamer in combination with radiotherapy results in enhanced survival in DIPG models
Marta M Alonso
Favorite
IMMU-39 - TIM-3 aptamer in combination with radiotherapy results in enhanced survival in DIPG models
Marta M Alonso
Favorite
Anderson, Kevin

The Jackson Laboratory for Genomic Medicine
EPCO-27 - Glioma single cell multi-omic analyses reveals regulators of plasticity and adaptive stress response
Kevin Anderson
Favorite
EPCO-27 - Glioma single cell multi-omic analyses reveals regulators of plasticity and adaptive stress response
Kevin Anderson
Favorite
Arrillaga-Romany, Isabel

Massachusetts General Hospital/Harvard Medical School
Panel Discussion
Isabel Arrillaga-Romany
Favorite
CTNI-37 - Efficacy of ONC201 in patients with ONC201 for recurrent H3 K27M-mutant diffuse midline glioma

Isabel Arrillaga-Romany
Favorite
Augustyn, Alexander

University of Texas MD Anderson Cancer Center
RADT-13 - Early concurrent immunotherapy with stereotactic radiosurgery is associated with prolonged survival and decreased distant brain failure in patients with newly diagnosed melanoma brain metastases (MBM)
Alexander Augustyn
Favorite
B
Baisiwala, Shivani

Northwestern Feinberg School of Medicine
CBIO-17 - Identifying A Network of Essential & Tumorigenic Genes In Glioblastoma Using Whole-Genome CRISPR Cas9 Screening
Shivani Baisiwala
Favorite
Balaj, Leonora

Massachusetts General Hospital
Considerations in Liquid Biopsy for Glioblastoma
Leonora Balaj
Favorite
Balogun, James

University College Hospital, Ibadan/University of Ibadan
Contemporary Neuro-Oncology in Sub-Saharan Africa: Mapping a Pathway and Building Synergy
James Balogun
Favorite
Bander, Evan

NY Presbyterian Hospital/Weill Cornell Medical Center
RADT-08 - Adjuvant SBRT for resected brain metastases: the effect of timing on long-term intended-field control
Evan Bander
Favorite
Barrette, Anne Marie

Stanford University
TMOD-23 - A novel BRAF V600E low-grade glioma mouse model highlights exomic and tumor immune alterations and differing therapeutic responses in low- and high-grade gliomas
Anne Marie Barrette
Favorite
Barthel, Floris

The Jackson Laboratory for Genomic Medicine
EPCO-09 - Stereotactic image-guided epigenome profiling reveals diverse evolutionary growth routes in diffuse gliomas
Floris Barthel
Favorite
EPCO-09 - Stereotactic image-guided epigenome profiling reveals diverse evolutionary growth routes in diffuse gliomas
Floris Barthel
Favorite
Bartkowiak, Todd

Vanderbilt University
IMMU-16 - Two distinct subsets of natural killer cells are enriched in the tumor microenvironment and correlate with survival outcome in human glioblastoma.
Todd Bartkowiak
Favorite
Batchelor, Tracy

Brigham and Women's Hospital
Panel Discussion
Tracy Batchelor
Favorite
Beigi Masihi, Meher

Sanford Burnham Prebys Medical Discovery Institute
TMOD-30 - Identifying New Drivers of Group 3 Medulloblastoma
Meher Beigi Masihi
Favorite
Bettegowda, Chetan

Johns Hopkins School of Medicine
Panel Discussion
Chetan Bettegowda
Favorite
Bi, Wenya Linda

Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School
PATH-35 - A scalable molecularly Integrated Classifier for Meningioma outperforms WHO classification
Wenya Linda Bi
Favorite
Boisclair, Stephanie

Memorial Healthcare System
NCOG-27 - Increased overall survival among racial minorities and suboptimal use of standard of care treatment in glioblastoma multiforme
Stephanie Boisclair
Favorite
Bovi, Joseph

Dept. Radiation Oncology, Medical College of Wisconsin
NCOG-04 - Pretreatment volume of MR-determined white matter injury(WMI) predicts neurocognitive decline after hippocampal avoidant(HA)WBRT+Memantine for brain metastases: Secondary analysis of NRG OncologyCC001
Joseph Bovi
Favorite
Bowden, Stephen

Oregon Health and Science University
INNV-01 - Neurologic improvement with corticosteroids prior to surgery is predictive of durable post-operative improvement in motor deficits due to brain metastases
Stephen Bowden
Favorite
Bracci, Paige

Department of Epidemiology & Biostatistics , UCSF, San Francisco, CA, USA
EPID-08 - Pre-surgery immune profiles of adult glioma patients
Paige Bracci
Favorite
Brennan, Paul

University of Edinburgh
Panel Discussion
Paul Brennan
Favorite
Spectroscopy and Liquid Biopsies
Paul Brennan
Favorite
Brenner, Andrew

Mays Cancer Center UT Health Science Center, San Antonio
CTNI-07 - Delivery and activity of SN-38 by Sacituzumab Govitecan in CNS Tumors
Andrew Brenner
Favorite
Broestl, Lauren

Washington University School of Medicine
CBIO-08 - Astrocyte senescence contributes to sex differences in glioblastoma incidence and outcome.
Lauren Broestl
Favorite
Buck, Elizabeth

Black Diamond Therapeutics, Inc.
EXTH-59 - Potent, selective, and brain penetrant inhibitors of extracellular domain EGFR oncogenic mutants expressed in GBM demonstrate efficacy in an intracranial patient derived xenograft model
Elizabeth Buck
Favorite
Bunda, Severa

MacFeeters Hamilton Centre for Neuro-Oncology Research
CSIG-07 - c-Src phosphorylates and inactivates the CIC tumor suppressor protein in glioblastoma
Severa Bunda
Favorite
Bunse, Lukas

University of Heidelberg and DKFZ
IMMU-41 - High-throughput retrieval of therapeutic T cell receptors from glioma
Lukas Bunse
Favorite
IMMU-41 - High-throughput retrieval of therapeutic T cell receptors from glioma
Lukas Bunse
Favorite
Butt, Omar

Washington University in Saint Louis
NCMP-24 - Pre-infusion neurofilament light chain (NfL) levels predict the development of immune effector cell-associated neurotoxicity syndrome (ICANS)
Omar Butt
Favorite
C
Cacciotti, Chantel

Dana-Farber/ Boston Children’s Cancer and Blood Disorders Center
NCOG-63 - Pediatric Neuro-Oncology Survivor Identity: A Project REACH Study
Chantel Cacciotti
Favorite
Cai, Linbo

Guangdong Sanjiu Brain Hospital
CTNI-60 - Neoajuvant Chemotherapy Followed by Craniospinal Irradiation for intracranial NGGCTs: Clinical Outcomes and Age-stratified Toxicities in a Cohort of 111 Patients
Linbo Cai
Favorite
Campian, Jian

Washington University School of Medicine
EXTH-14 - A novel long-acting interleukin-7 agonist, NT-I7, increases cytotoxic CD8 cells and enhances survival in mouse glioma models
Jian Campian
Favorite
Carnevale, Joseph

Memorial Sloan Kettering Cancer Center
SURG-01 - Risk of Tract Recurrence with Stereotactic Biopsy of Brain Metastases: an 18-year Cancer Center Experience
Joseph Carnevale
Favorite
Chandra, Joya

University of Texas MD Anderson Cancer Center
EXTH-67 - Pharmacologic inhibition of lysine specific demethylase-1 (LSD1) as an adjuvant immune-sensitization strategy in diffuse intrinsic pontine glioma (DIPG)
Joya Chandra
Favorite
Chang, Enoch

Department of Therapeutic Radiology, Yale School of Medicine
NIMG-03 - Deep Learning Survival Analysis for Multiple Brain Metastases

Enoch Chang
Favorite
NIMG-03 - Deep Learning Survival Analysis for Multiple Brain Metastases

Enoch Chang
Favorite
Chang, Susan

University of California San Francisco
Panel Discussion
Susan Chang
Favorite
Chen, Clark

University of Minnesota
EPCO-19 - Integrated analysis of intra-tumoral heterogeneity in glioblastomas through single nuclei ATAC-Seq and RNA-Seq
Clark Chen
Favorite
TAMI-41 - PI3K-gamma inhibition suppresses accumulation of glioblastoma-associated microglia to recapitulate the microenvironment of exceptional responders
Clark Chen
Favorite
Chheda, Milan

Washington University School of Medicine
SNO Survey: The State of Neuro-Oncology During the COVID-19 Pandemic: A Worldwide Assessment
Milan Chheda
Favorite
Chiocca, E.Antonio

Brigham and Women's Hospital and Harvard Medical School
CTIM-05 - Combination of Controlled Interleukin-12 Gene Therapy with Immune Checkpoint Blockade in Recurrent Glioblastoma: Updated Results of a Multi-Institutional, Open Label Phase 1 Trial
E.Antonio Chiocca
Favorite
Choi, Seung Won

Samsung Medical Center
CBIO-04 - Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Seung Won Choi
Favorite
NIMG-20 - Multi-habitat radiomics unravels distinct phenotypic subtypes of glioblastoma with clinical and genomic significance
Seung Won Choi
Favorite
Choudhury, Abrar

University of California, San Franicsco
EPCO-36 - Genomic instability and transcriptomic signatures underlying epigenetic meningioma subgroups reveals mechanisms of immune infiltration and therapeutic vulnerabilities
Abrar Choudhury
Favorite
Chunduru, Pranathi

UCSF
PATH-31 - Artificial intelligence in glioma pathology image analysis for risk prediction.
Pranathi Chunduru
Favorite
Chuntova, Polly

University of California, San Francisco
EXTH-15 - Inhibition of 2-HG leads to upregulation of a pro-inflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1^R132H-expressing glioma
Polly Chuntova
Favorite
Cloughesy, Timothy

University of California Los Angeles
Introduction
Timothy Cloughesy
Favorite
Town Hall: Clinical Trial Designs in 2020 and Beyond
Timothy Cloughesy
Favorite
Costello, Joseph

Department of Neurological Surgery, University of California San Francisco
Introduction
Joseph Costello
Favorite
Panel Discussion
Joseph Costello
Favorite
Roundtable: Single Cell Sequencing of Brain Tumors
Joseph Costello
Favorite
D
Daggubati, Vikas

University of California, San Franicsco
DDRE-29 - Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma
Vikas Daggubati
Favorite
Day, Charles

University of Minnesota/Mayo Clinic
CBIO-16 - Suppression of histone H3.3 mitotic phosphorylation drives development of H3K27M-mutant diffuse midline gliomas

Charles Day
Favorite
de Carvalho, Daniel

Princess Margaret Cancer Center
Keynote: Liquid Biopsies in Cancer
Daniel de Carvalho
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 1
Daniel de Carvalho
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 2
Daniel de Carvalho
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 3
Daniel de Carvalho
Favorite
Panel Discussion
Daniel de Carvalho
Favorite
Panel Discussion
Daniel de Carvalho
Favorite
Welcome
Daniel de Carvalho
Favorite
de Gooijer, Mark

Netherlands Cancer Institute
RBIO-05 - Mitotic enrichment as an efficient strategy to radiosensitize glioblastoma
Mark de Gooijer
Favorite
De La Fuente, Macarena

Sylvester Comprehensive Cancer Center, University of Miami
CTIM-06 - Dendritic cell vaccine study for recurrent, high-grade glioma: tissue-based RNA sequencing and serum cytokine levels as potential biomarkers
Macarena De La Fuente
Favorite
De Martino, Mara

Weill Cornell Medicine
TAMI-27 - Radiation therapy reprograms the tumor metabolism to promote survival and immunosuppression in glioblastoma
Mara De Martino
Favorite
Deleyrolle, Loic

University of Florida
TAMI-19 - Metabolic interactions between tumor cells and the immune system in GBM: A potential Achilles heel of GBM for novel therapeutics
Loic Deleyrolle
Favorite
Dhawan, Sanjay

University of Minnesota
STEM-12 - Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α_vβ₅ Axis
Sanjay Dhawan
Favorite
Diaz, Aaron

University of California San Francisco
EPCO-17 - A single-cell atlas of glioblastoma evolution under therapy

Aaron Diaz
Favorite
EPCO-32 - An epigenetic single-cell atlas of IDH-mutant glioma reveals the role of ATRX in shaping tumor composition
Aaron Diaz
Favorite
EPCO-32 - An epigenetic single-cell atlas of IDH-mutant glioma reveals the role of ATRX in shaping tumor composition
Aaron Diaz
Favorite
Diaz, Maria

Memorial Sloan Kettering Cancer Center
BIOM-05 - Circulating tumor cells (CTC) in cerebrospinal fluid (CSF) as a predictor of survival in CNS metastases
Maria Diaz
Favorite
BIOM-05 - Circulating tumor cells (CTC) in cerebrospinal fluid (CSF) as a predictor of survival in CNS metastases
Maria Diaz
Favorite
E
Ellingson, Benjamin

University of California Los Angeles
NIMG-28 - Validation of modified response assessment in neuro oncology (mRANO) determined PFS as a strong predictor of overall survival in recurrent glioblastoma treated with a targeted immunotoxin
Benjamin Ellingson
Favorite
Englinger, Bernhard

Dana-Farber Cancer Institute
EPCO-35 - Single-cell RNA-seq of pediatric ependymoma reveals prognostic impact of impaired neuronal-glial fate specification
Bernhard Englinger
Favorite
EPCO-35 - Single-cell RNA-seq of pediatric ependymoma reveals prognostic impact of impaired neuronal-glial fate specification
Bernhard Englinger
Favorite
Eoli, Marica

Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta
BIOM-10 - Prevalence of NF1 missense mutations and candidate modifier genes in spinal neurofibromatosis patients
Marica Eoli
Favorite
Epelbaum, Julia

Donald and Barbara Zucker School of Medicine at Northwell/Hofstra
INNV-07 - The role of biopsy in molecular diagnosis of diffuse intrinsic pontine glioma patients
Julia Epelbaum
Favorite
Erker, Craig

Dalhousie University
NCOG-47 - Can young children with relapsed medulloblastoma be salvaged after initial irradiation-sparing approaches?
Craig Erker
Favorite
F
Fan, Yi

UNIVERSITY OF PENNSYLVANIA
TAMI-26 - Single-cell transcriptome analysis reveals that endothelial transformation drives glioblastoma chemoresistance via Wnt/β-catenin/MRP-1
Yi Fan
Favorite
Farouk Sait, Sameer

Memorial Sloan Kettering Cancer Center
CTNI-33 - Debio1347, an oral FGFR inhibitor: results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas
Sameer Farouk Sait
Favorite
Fathi Kazerooni, Anahita

University of Pennsylvania
NIMG-40 - Radiogenomic Signatures of Driver Genes in Newly Diagnosed Glioblastoma Patients Based on Pre-operative Multi-Parametric MRI
Anahita Fathi Kazerooni
Favorite
Fernandez, Elizabeth

UCLA
CBIO-25 - Integrated molecular and BH3 profiling of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioblastoma
Elizabeth Fernandez
Favorite
Fountain, Daniel

Geoffrey Jefferson Brain Research Centre, Salford Royal NHS Foundation Trust and the University of Manchester
COVD-15 - CovidNeuroOnc: a UK multi-centre, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology service
Daniel Fountain
Favorite
Friedel, Roland H.

Icahn School of Medicine at Mount Sinai
TMOD-22 - Akaluc bioluminescence offers superior sensitivity to track in vivo GBM expansion
Roland H. Friedel
Favorite
Furnari, Frank

University of California, San Diego
Introduction
Frank Furnari
Favorite
Panel Discussion
Frank Furnari
Favorite
Roundtable: What's New in the Tumor Microenvironment?
Frank Furnari
Favorite
G
Gaiti, Federico

Weill Cornell Medical College
EPCO-14 - Deciphering differentiation hierarchies, heritability and plasticity in human gliomas via single-cell multi-omics
Federico Gaiti
Favorite
Galanis, Evanthia

Mayo Clinic
Panel Discussion
Evanthia Galanis
Favorite
Gallo, Marco

University of Calgary
STEM-29 - The histone variant macroH2A2 orchestrates an actionable chromatin program of stemness in glioblastoma
Marco Gallo
Favorite
Gardner, Sharon

Division of Pediatric Neuro-Oncology, Department of Pediatrics, NYU Grossman School of Medicine, NYU Langone Health
CTNI-15 - Clinical efficacy of ONC201 in newly diagnosed DIPG and in previously irradiated pediatric H3 K27M-mutant gliomas
Sharon Gardner
Favorite
Gilbert, Mark

National Cancer Institute
Panel Discussion
Mark Gilbert
Favorite
Ginalis, Elizabeth

Rutgers-New Jersey Medical School; Rutgers-Robert Wood Johnson Medical School
NCOG-65 - MR-guided laser interstitial thermal therapy for brain tumors in geriatric patients
Elizabeth Ginalis
Favorite
Goldbrunner, Roland

University Hospital Cologne
(EANO) Overview of new EANO meningioma guidelines
Roland Goldbrunner
Favorite
Graber, Jerome

University of Washington
QOLP-26 - Use of medical assistance in dying (“Death with Dignity”) in Washington state patients with brain tumors.
Jerome Graber
Favorite
Grabowski, Matthew

Department of Neurosurgery, Cleveland Clinic
SURG-03 - Combination Laser Interstitial Thermal Therapy Plus SRS Increases Time to Progression for Recurrent SRS-Treated Brain Metastases
Matthew Grabowski
Favorite
Grossman, Rachel

Tel-Aviv Medical Center
SURG-30 - Surgical resection of primary central nervous system lymphoma: impact of patient selection on overall survival
Rachel Grossman
Favorite
Gupta, Mihir

University of California San Diego
BIOM-54 - A Rapid Genotyping Panel for Sensitive and Specific Segregation of CNS Pathologies
Mihir Gupta
Favorite
Gupta, Pravesh

MD Anderson Cancer Center
IMMU-35 - Transcriptionally defined immune contexture in human gliomas at single-cell resolution
Pravesh Gupta
Favorite
Gupte, Trisha

Department of Neurosurgery, Yale School of Medicine
NCOG-50 - Clinical and Genomic Factors Associated with Seizures in Meningiomas
Trisha Gupte
Favorite
H
Haddad, Alexander

University of California, San Francisco Department of Neurological Surgery
EXTH-17 - Local delivery of cytokines and synthetic immunomodulators increases T cell infiltration and significantly improves survival in a poorly immunogenic model of glioblastoma
Alexander Haddad
Favorite
Hagiwara, Akifumi

University of California, Los Angeles
NIMG-49 - Validation of simultaneous pH- and O₂-weighted molecular MRI using ¹⁸F-FDG PET, immunohistochemistry, and bioenergetics
Akifumi Hagiwara
Favorite
Hashizume, Rintaro

Northwestern University Feinberg School of Medicine
Discussant
Rintaro Hashizume
Favorite
Hausmann, David

Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
CSIG-18 - Calcium communication in glioma: crucial pacemaker cells govern tumor progression
David Hausmann
Favorite
Haydar, Dalia

St Jude Children's Research Hospital
EXTH-20 - Syngeneic B7-H3-specific CAR T-cells have potent anti-brain tumor activity via local or systemic delivery
Dalia Haydar
Favorite
Hayden Gephart, Melanie

Stanford University
Discussant
Melanie Hayden Gephart
Favorite
Haynes, Chas

Society for Neuro-Oncology
Esenwein Award Presentation and Presidential Introduction

Chas Haynes
Favorite
What's New at SNO
Chas Haynes
Favorite
Hegi, Monika

Lausanne University Hospital
Introduction
Monika Hegi
Favorite
Introduction
Monika Hegi
Favorite
Keynote Introduction
Monika Hegi
Favorite
Keynote Introduction
Monika Hegi
Favorite
Mario Suva Keynote
Monika Hegi
Favorite
Panel Discussion
Monika Hegi
Favorite
Roundtable: Single Cell Sequencing of Brain Tumors
Monika Hegi
Favorite
Top Abstract and Daniel De Carvalho Keynote
Monika Hegi
Favorite
Top Abstracts and Ed Lein Keynote
Monika Hegi
Favorite
Top Abstracts and Paul Northcott Keynote
Monika Hegi
Favorite
Town Hall: COVID-19 and Neuro-Oncology
Monika Hegi
Favorite
Welcome and Introduction
Monika Hegi
Favorite
Heiland, Dieter

Medical-Center, University of Freiburg
IMMU-34 - Landscape of glioblastoma-associated immunity by integration of scRNA-seq and spatial transcriptomics
Dieter Heiland
Favorite
IMMU-34 - Landscape of glioblastoma-associated immunity by integration of scRNA-seq and spatial transcriptomics
Dieter Heiland
Favorite
TAMI-53 - The oncometabolite D-2HG induce inflammatory astrogliosis causing neurotoxicity and seizures in IDH mutated glioma
Dieter Heiland
Favorite
Heimberger, Amy

MD Anderson Cancer Center
Abhijit Guha Award Lecture: The Immune Landscape of CNS tumors: Implications for Immunotherapy

Amy Heimberger
Favorite
Panel Discussion
Amy Heimberger
Favorite
Hervey-Jumper, Shawn

UCSF
SURG-07 - Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering microscopy
Shawn Hervey-Jumper
Favorite
SURG-18 - The impact of neurologic impairments on the relative benefit of maximal extent of resection in newly diagnosed IDH-wild type glioblastoma
Shawn Hervey-Jumper
Favorite
TAMI-21 - Malignant gliomas remodel functional neural circuits through paracrine signaling which confers a negative prognosis
Shawn Hervey-Jumper
Favorite
Hong, Yong-Kil

Seoul St. Mary's Hospital The Catholic University of Korea
(ASNO) Discussion
Yong-Kil Hong
Favorite
(ASNO) Perspectives of the WFNOS
Yong-Kil Hong
Favorite
Hori, Yusuke

Cleveland Clinic
INNV-03 - Efficacy and long-term outcomes in the management of large brain metastasis (≥ 4 cm³) using 2-staged Stereotactic radiosurgery (2-SSRS): an international study
Yusuke Hori
Favorite
Horta, Erika

University of Arkansas for Medical Sciences (UAMS)
NCOG-18 - Is the RANO Criteria for low-grade glioma reliable in the clinical setting? – A reliability study
Erika Horta
Favorite
Huang, Annie

The Hospital for Sick Children
Introduction
Annie Huang
Favorite
Panel Discussion
Annie Huang
Favorite
Roundtable: What's New in Pediatric Neuro-Oncology?
Annie Huang
Favorite
Huang, Raymond

Brigham and Women's Hospital
Introduction
Raymond Huang
Favorite
Panel Discussion
Raymond Huang
Favorite
Roundtable: Using Artificial Intelligence in the Clinic Setting
Raymond Huang
Favorite
Hwang, Eugene

Children's National Hospital
CTIM-33 - The ReMIND trial: multi-antigen targeted T cells for pediatric CNS tumors
Eugene Hwang
Favorite
I
Ichimura, Koichi

Division of Brain Tumor Translational Research, National Cancer Center Research Institute
ISPNO2020 Hybrid Meeting Preview
Koichi Ichimura
Favorite
Idbaih, Ahmed

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, F-75013, Paris, France
CTNI-31 - Interim results of a phase I/IIa study to evaluate the safety and efficacy of BBB opening with the SonoCloud-9 implantable ultrasound device in recurrent glioblastoma patients prior to IV carboplatin
Ahmed Idbaih
Favorite
Iorgulescu, Bryan

Brigham and Women's Hospital, Dana-Farber Cancer Institute
NCOG-09 - Effectiveness of HER2-targeted antibody therapy in HER2-positive breast cancer brain metastases: a national analysis
Bryan Iorgulescu
Favorite
J
Jackson, Christina

Johns Hopkins University School of Medicine
IMMU-27 - Single cell RNA-sequencing identifies novel bone marrow derived myeloid cells in glioblastoma associated with tumor aggression
Christina Jackson
Favorite
Jackson, Christopher

Johns Hopkins University Department of Neurosurgery
Discussant
Christopher Jackson
Favorite
Jaeckle, Kurt

Mayo Clinic Florida
CTNI-29 - CODEL: Phase III trial of RT alone, RT plus TMZ, or TMZ alone for newly-diagnosed, 1p/19q codeleted anaplastic oligodendroglioma. Analysis from the initial study design.(NCCTG N0577, Alliance)
Kurt Jaeckle
Favorite
Jalali, Rakesh

Apollo Proton Cancer Centre
(ASNO) Discussion
Rakesh Jalali
Favorite
(ASNO) Strengthening Neuro-Oncology in India and South Asia
Rakesh Jalali
Favorite
Jiang, Li

Dana-Farber Boston Children's Cancer and Blood Disorders Center
EPCO-26 - Project HOPE: “Pediatric and AYA High-Grade Glioma Omics Project”- A longitudinal molecular landscape of high-grade gliomas resolved at single-cell level
Li Jiang
Favorite
Ji, Jianxiong

Mayo Clinic Rochester
EXTH-01 - Inhibition of DNA-PKcs by M3814 potentiates efficacy of ionizing radiation in Patient-derived xenografts of melanoma brain metastases
Jianxiong Ji
Favorite
Jin, Linchun

University of Florida
IMMU-38 - Preclinical validation and manufacture of IL-8 receptor-modified CD70 CAR T cells for clinical trial
Linchun Jin
Favorite
Jones, Jordan

University of Melbourne, Royal Melbourne Hospital
BIOM-49 - Serum microRNA is a prognostic and post-operative monitoring biomarker in glioma
Jordan Jones
Favorite
BIOM-49 - Serum microRNA is a prognostic and post-operative monitoring biomarker in glioma
Jordan Jones
Favorite
Joyce, Johanna

University of Lausanne
Keynote: Tumor Microenvironment
Johanna Joyce
Favorite
Panel Discussion
Johanna Joyce
Favorite
Jungwirth, Gerhard

Division of Experimental Neurosurgery, Department of Neurosurgery, Ruprechts-Karls-University Heidelberg
TAMI-61 - Tumor-Associated Macrophages Are Independent Prognostic Markers in Meningiomas
Gerhard Jungwirth
Favorite
K
Karanam, Narasimha Kumar

UT Southwestern Medical Center
CBIO-01 - Therapeutic implications of conditional vulnerabilities caused by TTFields exposure in novel combination therapies for non-small cell lung cancer and brain metastases from non-small cell lung cancer
Narasimha Kumar Karanam
Favorite
Karschnia, Philipp

Department of Neurosurgery, Ludwig-Maximilians-University School of Medicine
BIOM-15 - Subventricular zone involvement is associated with worse outcome in glioma WHO grade II independent of molecular markers
Philipp Karschnia
Favorite
Kawakibi, Abed Rahman

University of Michigan Medical School
CTNI-17 - Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
Abed Rahman Kawakibi
Favorite
Kayabolen, Alisan

Koç University Research Center for Translational Medicine
EXTH-10 - Combination of epigenetic enzyme inhibitors, GSK-J4 and Belinostat, reveals high efficacy in IDH1 mutant gliomas
Alisan Kayabolen
Favorite
Kebir, Sied

Department of Neurology, Division of Clinical Neurooncology, University Hospital Essen
PATH-15 - Deep learning enabled prediction of isocitrate dehydrogenase mutation status from digital histopathology data in glioblastoma
Sied Kebir
Favorite
PATH-15 - Deep learning enabled prediction of isocitrate dehydrogenase mutation status from digital histopathology data in glioblastoma
Sied Kebir
Favorite
Kessler, Ketty

Institute of Cancer Research
EPCO-05 - Loss of the H4 lysine methyltransferase KMT5B drives invasion / migration by depleting H3K27me3 at loci otherwise retained in H3K27M mutant DIPG cells
Ketty Kessler
Favorite
Kessler, Tobias

Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg
BIOM-39 - Establishment of a connectivity signature for gliomas
Tobias Kessler
Favorite
Khan, Raja B.

Saint Jude Children's Research Hospital
NCMP-25 - Clinical features, neurologic recovery, and risk prediction of post-operative posterior fossa syndrome: A prospective study
Raja B. Khan
Favorite
Kieliszek, Agata

McMaster University
STEM-01 - Targeting brain metastasis-initiating cells: a preventative approach
Agata Kieliszek
Favorite
Kim, Albert

Washington University School of Medicine
NCOG-53 - Predictors of endocrine outcome after endoscopic transsphenoidal surgery for non-functioning pituitary adenomas
Albert Kim
Favorite
Kim, In Ah

Seoul National University
CTNI-05 - NRG Oncology / RTOG 1119: Phase II randomized study of whole brain radiotherapy / stereotactic radiosurgery with concurrent lapatinib in patients with brain metastases from HER2-positive breast cancer
In Ah Kim
Favorite
Kitamura, Yohei

Tokyo Saiseikai Central Hospital
TMOD-01 - Developing clinically relevant brain metastatic tumor models for targeted stem cell therapeutics
Yohei Kitamura
Favorite
Kocakavuk, Emre

The Jackson Laboratory for Genomic Medicine
EPCO-15 - Tumor treatment with ionizing radiation is associated with a clinically relevant deletion signature
Emre Kocakavuk
Favorite
Koga, Tomoyuki

Department of Neurosurgery, University of Minnesota
TMOD-07 - Human diffuse midline glioma avatars as a platform to search for novel therapeutic targets
Tomoyuki Koga
Favorite
Kothari, Shawn

University of Pennsylvania
PATH-25 - Experience with an RNA fusion transcript panel for detection of potential therapeutic targets in gliomas
Shawn Kothari
Favorite
Kovalchick, Laurel

Virginia Commonwealth University
QOLP-22 - Posttraumatic growth in neuro-oncology
Laurel Kovalchick
Favorite
Kumar, Anupam

Department of Neurological Surgery, University of California San Francisco
TAMI-07 - The immune microenvironment in lower grade gliomas
Anupam Kumar
Favorite
Kumthekar, Priya

Department of Neurology, Northwestern University
QOLP-02 - Patient-reported outcomes following pertuzumab plus high-dose trastuzumab in patients with HER2-positive metastatic breast cancer (MBC) and central nervous system (CNS) progression post-radiotherapy
Priya Kumthekar
Favorite
L
Ladomersky, Erik

Northwestern University
IMMU-40 - Improving Outcomes in Older Adults with Glioblastoma By Reversing Age-Related Changes of the Central Nervous System
Erik Ladomersky
Favorite
Lamouille, Samy

Fralin Biomedical Research Institute at Virginia Tech Carilion
STEM-28 - Nanoparticles encapsulating a connexin43 mimetic peptide limit glioma stem cell survival and glioblastoma progression.
Samy Lamouille
Favorite
Lamszus, Katrin

University Medical Center Hamburg-Eppendorf
Extracellular Vesicles and Circulating Tumour Cells
Katrin Lamszus
Favorite
Laspidea, Virginia

Universidad de Navarra
IMMU-14 - Oncolytic adenovirus Delta-24-RGD engineered to express 4-1BBL as a therapeutic approach for DIPG
Virginia Laspidea
Favorite
Lassman, Andrew

Columbia University Irving Medical Center/New York-Presbyterian Hospital
A randomized, double-blind, placebo-controlled phase 3 trial of depatuxizumab mafodotin (ABT-414) in Epidermal Growth Factor Receptor (EGFR) amplified (amp) newly diagnosed glioblastoma (nGBM)
Andrew Lassman
Favorite
Panel Discussion
Andrew Lassman
Favorite
Panel Discussion
Andrew Lassman
Favorite
CTNI-18 - Final Results of a Phase 2 Study of Efficacy, Safety and Intratumoral Pharmacokinetics (PK) of Selinexor Monotherapy in Recurrent Glioblastoma (rGBM)
Andrew Lassman
Favorite
Lathia, Justin

Cleveland Clinic
Discussant
Justin Lathia
Favorite
Lauko, Adam

Cleveland Clinic
STEM-07 - Identification of a novel CSC signaling axis containing JAM-A/SerpinB3/TGF-beta
Adam Lauko
Favorite
Law, Vincent

H. Lee Moffitt Cancer Center & Research Institute
EXTH-04 - Intrathecal (IT) Delivery of Type I Polarized Dendritic Cell Vaccine (DC1) Eradicates Tumor Growth in Breast Cancer (BC) Xenograft Model with Brain Metastases (BM) and Leptomeningeal Disease (LMD)
Vincent Law
Favorite
TMOD-02 - In Vitro & In Vivo Culture of Patient Derived (PD) CSF-CTCs in Leptomeningeal Disease (LMD) From Melanoma to Identify Novel Treatment Strategies
Vincent Law
Favorite
Lazow, Margot

Cincinnati Childen's Hospital Medical Center
PATH-13 - Characterizing Temporal Genomic Heterogeneity in Pediatric Low-Grade Gliomas
Margot Lazow
Favorite
Le Rhun, Emilie

Zurich University Hospital
NCOG-02 - Prognostic validation of the EANO ESMO classification of leptomeningeal metastasis

Emilie Le Rhun
Favorite
Lee, Alexander

University of California Los Angeles
IMMU-20 - Single-cell RNAseq of tumor infiltrating immune cells from neoadjuvant anti-PD1 treated GBM patients reveals global transcriptional changes and immunosuppressive adaptive responses by myeloid cells
Alexander Lee
Favorite
IMMU-20 - Single-cell RNAseq of tumor infiltrating immune cells from neoadjuvant anti-PD1 treated GBM patients reveals global transcriptional changes and immunosuppressive adaptive responses by myeloid cells
Alexander Lee
Favorite
Lee, Eudocia

Dana Farber Cancer Institute
CTNI-47 - Phase II study of abemaciclib in recurrent GBM patients with CDKN2A/B loss and intact RB
Eudocia Lee
Favorite
Lein, Ed

Allen Institute for Brain Science
Keynote: The Power and Future of Single Cell Technologies
Ed Lein
Favorite
Panel Discussion
Ed Lein
Favorite
Li, Gordon

Neurosurgery, Stanford University School of Medicine
Discussant
Gordon Li
Favorite
Lim-Fat, Mary Jane

Sunnybrook Health Sciences Centre
BIOM-44 - Genomic predictors of adverse events in newly diagnosed IDH-wildtype glioblastoma
Mary Jane Lim-Fat
Favorite
EPID-11 - A multi-institutional comparative analysis of the clinical, genomic, and survival characteristics of pediatric, young adult and older adult patients with IDH-mutant glioma

Mary Jane Lim-Fat
Favorite
PATH-03 - Clinical utility of next generation sequencing in IDH-wildtype glioblastoma: the Dana-Farber Cancer Institute experience.
Mary Jane Lim-Fat
Favorite
Lim, Michael

Stanford University School of Medicine, Department of Neurosurgery
Abhijit Guha Award Introduction
Michael Lim
Favorite
Introduction
Michael Lim
Favorite
Introduction
Michael Lim
Favorite
Panel Discussion
Michael Lim
Favorite
Roundtable: What's New in the Tumor Microenvironment?
Michael Lim
Favorite
Top Abstracts and Daniel Orringer, Amy Heimberger and Johanna Joyce Keynotes
Michael Lim
Favorite
Top Abstracts and Vinay Prasad Keynote
Michael Lim
Favorite
Town Hall: COVID-19 and Neuro-Oncology
Michael Lim
Favorite
Welcome
Michael Lim
Favorite
Lomeli, Naomi

University of California, Irvine
NCMP-16 - The role of p38 and JNK MAPK pathways in cisplatin chemotherapy-related cognitive impairment
Naomi Lomeli
Favorite
Loughan, Ashlee

Virginia Commonwealth University
QOLP-18 - A call to action: Death anxiety in neuro-oncology
Ashlee Loughan
Favorite
Lukas, Rimas

Northwestern Memorial Hospital
CTIM-28 - Phase 2 Trial of Controlled IL-12 in Combination with PD-1 Inhibitor in Adult Subjects with Recurrent Glioblastoma (rGBM)
Rimas Lukas
Favorite
Lwin, Zarnie

Royal Brisbane and Women's Hospital
(ASNO) Discussion
Zarnie Lwin
Favorite
(ASNO) Outreach and Collaboration
Zarnie Lwin
Favorite
M
Mahajan, Anita

Mayo Clinic
Discussant
Anita Mahajan
Favorite
Maldaun, Marcos

Hospital Sírio Libanes , São Paulo , Brazil
Update on the Society for Neuro-Oncology Latin America
Marcos Maldaun
Favorite
Malueka, Rusdy

Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
(ASNO) Discussion
Rusdy Malueka
Favorite
(ASNO) Strength and Weakness of Neuro-Oncology Service in Indonesia
Rusdy Malueka
Favorite
Mandal, Ayan

University of Cambridge
NIMG-13 - Genetic, cellular, and connectomic characterization of the adult human brain regions commonly plagued by glioma
Ayan Mandal
Favorite
Markwell, Steven

Northwestern University
TAMI-56 - Hypoxia-driven necrosis drives dynamic tumor progression in glioblastoma
Steven Markwell
Favorite
Martirosian, Vahan

University of Southern California
TAMI-57 - Medulloblastoma Utilize GABA Transaminase to Survive in the Cerebrospinal Fluid Microenvironment and Promote Leptomeningeal Dissemination
Vahan Martirosian
Favorite
Mathur, Radhika

University of California San Francisco
EPCO-31 - Epigenomic intratumoral heterogeneity of glioblastoma in three-dimensional space

Radhika Mathur
Favorite
McDonald, Malcolm

Baylor College of Medicine
EXTH-18 - Engineered Exosomes as Gene Delivery Tools for the Treatment of Glioblastoma
Malcolm McDonald
Favorite
McFarland, Braden

University of Alabama at Birmingham
TMOD-19 - Individual specific human gut microbe communities influence response to immunotherapy in a humanized microbiome mouse model of glioma
Braden McFarland
Favorite
Medikonda, Ravi

Johns Hopkins
NCOG-32 - The safety and efficacy of dexamethasone in the management of glioma patients
Ravi Medikonda
Favorite
Mehta, Minesh

Miami Cancer Institute
Panel Discussion
Minesh Mehta
Favorite
Meredith, David

Department of Pathology, Brigham and Women's Hospital
TMOD-34 - Patient-derived xenograft and cell line models facilitate novel treatment discovery in central nervous system lymphomas
David Meredith
Favorite
Michealraj, Antony

Sickkids
TAMI-59 - Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
Antony Michealraj
Favorite
Miller, Alexandra

Memorial Sloan Kettering Cancer Center
BIOM-56 - The integration of a liquid biopsy program into the care of pediatric brain tumor patients
Alexandra Miller
Favorite
BIOM-56 - The integration of a liquid biopsy program into the care of pediatric brain tumor patients
Alexandra Miller
Favorite
Molinaro, Annette

Department of Neurological Surgery, University of California (UCSF), San Francisco, San Francisco, CA, USA
EPCO-25 - An immunomethylomic platform integrating systemic immune profiles and epigenetic age in neuro-oncology
Annette Molinaro
Favorite
Monje, Michelle

Stanford University School of Medicine
Panel Discussion
Michelle Monje
Favorite
Morrow, Danielle

University of California Los Angeles
CBIO-05 - Lipid metabolic reprogramming sensitizes a molecularly-defined subset of glioblastomas to ferroptosis
Danielle Morrow
Favorite
Mouliere, Florent

Amsterdam Universitair Medische Centre
Decoding Circulating Nucleic Acids Biology
Florent Mouliere
Favorite
Mrugala, Maciej

Mayo Clinic Arizona
Panel Discussion
Maciej Mrugala
Favorite
Mueller, Sabine

University of California, San Francisco
DDRE-10 - Immune profiles associate with outcomes in HLA-A*02:01⁺, H3.3K27M⁺ patients with diffuse midline gliomas treated with H3.3K27M peptide vaccine combined with Poly-ICLC: a PNOC report
Sabine Mueller
Favorite
Mukherjee, Joydeep

UCSF
CSIG-19 - The deubiquitinase BRCC3 links ALT telomeres to suppression of innate immunity in IDH1-mutant glioma.
Joydeep Mukherjee
Favorite
Muragaki, Yoshihiro

Tokyo Women's Medical University
NIMG-08 - Prediction of lower-grade glioma molecular subtypes using deep learning
Yoshihiro Muragaki
Favorite
NIMG-08 - Prediction of lower-grade glioma molecular subtypes using deep learning
Yoshihiro Muragaki
Favorite
Mussa, Zarmeen

Icahn School of Medicine at Mount Sinai
EPCO-20 - Relating glioblastoma heterogeneity to human fetal glial development through high resolution single nuclei transcriptomics
Zarmeen Mussa
Favorite
N
Nagashima, Hiroaki

Massachusetts General Hospital, Harvard Medical School
TAMI-20 - Poly(ADP-ribose) glycohydrolase inhibition sequesters NAD+ to potentiate the metabolic lethality of alkylating chemotherapy in IDH mutant tumor cells
Hiroaki Nagashima
Favorite
Nassiri, Farshad

University of Toronto
Closing Remarks and Introduction of Roundtables
Farshad Nassiri
Favorite
Introduction
Farshad Nassiri
Favorite
Introduction
Farshad Nassiri
Favorite
Keynote Introduction
Farshad Nassiri
Favorite
Keynote Introduction
Farshad Nassiri
Favorite
Mario Suva Keynote
Farshad Nassiri
Favorite
Panel Discussion
Farshad Nassiri
Favorite
Roundtable: Liquid Biopsies In Neuro-Oncology
Farshad Nassiri
Favorite
Top Abstract and Daniel De Carvalho Keynote
Farshad Nassiri
Favorite
Top Abstracts and Ed Lein Keynote
Farshad Nassiri
Favorite
Top Abstracts and Paul Northcott Keynote
Farshad Nassiri
Favorite
Town Hall: COVID-19 and Neuro-Oncology
Farshad Nassiri
Favorite
BIOM-62 - Sensitive Detection and Discrimination of Intracranial Tumors by Blood
Farshad Nassiri
Favorite
Nevel, Kathryn

Indiana University School of Medicine
EPID-07 - Access to Glioblastoma Clinical Trials for Rural Patients in the United States from 2010-2020
Kathryn Nevel
Favorite
Nguyen, Teresa

MD Anderson Cancer Center
EXTH-45 - Delta-24-RGDOX activation of the IDO-Kyn-AhR cascade in glioblastoma: old targets for a new therapy.
Teresa Nguyen
Favorite
Nishikawa, Ryo

Saitama Medical University International Medical Center
(ASNO) Discussion
Ryo Nishikawa
Favorite
Nishikawa, Ryo

Department of Neurosurgery/NeuroOncology, Saitama Medical University International Medical Center
Friends of SNO
Ryo Nishikawa
Favorite
Northcott, Paul

St Jude Children Research Hospital
Keynote: Landscape of Pediatric Brain Tumors
Paul Northcott
Favorite
Panel Discussion
Paul Northcott
Favorite
Noushmehr, Houtan

Hermelin Brain Tumor Center, Henry Ford Health System
Application of Non-Invasive Epigenetics to Monitor Glioma Progression
Houtan Noushmehr
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 1
Houtan Noushmehr
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 2
Houtan Noushmehr
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 3
Houtan Noushmehr
Favorite
Panel Discussion
Houtan Noushmehr
Favorite
Panel Discussion
Houtan Noushmehr
Favorite
Welcome
Houtan Noushmehr
Favorite
O
Oliver, Kathy

International Brain Tumour Alliance (IBTA)
IBTA Survey: Brain tumours and COVID-19: the patient and caregiver experience
Kathy Oliver
Favorite
Panel Discussion
Kathy Oliver
Favorite
Orringer, Daniel

New York University
Keynote: Harnessing Big Data for Clinical Use
Daniel Orringer
Favorite
Panel Discussion
Daniel Orringer
Favorite
Ostrom, Quinn

Baylor College of Medicine
EPID-19 - Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US
Quinn Ostrom
Favorite
Osuka, Satoru

Department of Neurosurgery, School of Medicine and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham
STEM-16 - IGF1/N-cadherin/b-catenin/Clusterin signaling axis mediates adaptive radioresistance in glioblastoma
Satoru Osuka
Favorite
Otvos, Balint

Cleveland Clinic
IMMU-08 - Modeling upfront glioblastoma surgical resection and steroid use reveals immunosuppressive changes and suggests that peripheral lymphocyte counts are associated with tumor volume and prognosis
Balint Otvos
Favorite
P
Panditharatna, Eshini

Dana-Farber Cancer Institute
EXTH-37 - Targeting epigenetic vulnerabilities identified from a CRISPR screen in H3.3K27M DIPG
Eshini Panditharatna
Favorite
Perreault, Sébastien

CHU Sainte Justine, Montreal
CTNI-24 - A Phase 2 study of trametinib for patients with pediatric glioma with activation of the MAPK/ERK pathway. TRAM-01
Sébastien Perreault
Favorite
CTNI-67 - Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: an expanded dataset
Sébastien Perreault
Favorite
Peters, Katherine

Duke University Medical Center
NCOG-38 - Clinical Characteristics of Low Grade Glioma Patients with Non-Canonical IDH1 and IDH2 Mutations
Katherine Peters
Favorite
Phallen, Jillian

Johns Hopkins University School of Medicine
Advances in Molecular Biomarkers and Liquid Biopsy in Brain Cancer
Jillian Phallen
Favorite
Phillips, Lynette

MD Anderson Cancer Center
TMOD-16 - A novel adenoviral-permissive, immunocompetent hamster glioma model to evaluate oncolytic adenoviral therapy
Lynette Phillips
Favorite
Pietras, Alexander

Lund University
TAMI-05 - The irradiated brain microenvironment supports glioma stemness and survival via astrocyte-derived transglutaminase 2
Alexander Pietras
Favorite
Plotkin, Scott

Massachusetts General Hospital
CTNI-10 - Maintenance chemotherapy using bevacizumab for neurofibromatosis 2 patients with hearing loss and progressive vestibular schwannomas: an NF Clinical Trials Consortium study (NF104)
Scott Plotkin
Favorite
Pope, Whitney

University of California, Los Angeles
Introduction
Whitney Pope
Favorite
Panel Discussion
Whitney Pope
Favorite
Roundtable: Using Artificial Intelligence in the Clinic Setting
Whitney Pope
Favorite
Prabhu, Roshan

Levine Cancer Institute, Atrium Health
RADT-15 - Preoperative single fraction radiosurgery versus postoperative fractionated radiosurgery for resected brain metastases: a bi-institutional analysis of safety and clinical outcomes
Roshan Prabhu
Favorite
Prasad, Vinay

University of California, San Francisco
Keynote: Benefit from Genome-Driven Oncology
Vinay Prasad
Favorite
Panel Discussion
Vinay Prasad
Favorite
Praska, Corinne

Mayo Clinic
PATH-45 - Clinical utility of combined next generation sequencing and chromosomal microarray analysis for the diagnosis and management of adult gliomas
Corinne Praska
Favorite
Preusser, Matthias

Medical University of Vienna
(EANO) Systemic therapy of meningiomas
Matthias Preusser
Favorite
Friends of SNO
Matthias Preusser
Favorite
R
Rahman, Rifaquat

Brigham and Women's/Dana-Farber Cancer Center
CTNI-11 - CC-115 in newly diagnosed MGMT unmethylated glioblastoma in the Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): a phase II randomized Bayesian adaptive platform trial
Rifaquat Rahman
Favorite
Raviram, Ramya

New York Genome Center
EPCO-19 - Integrated analysis of intra-tumoral heterogeneity in glioblastomas through single nuclei ATAC-Seq and RNA-Seq
Ramya Raviram
Favorite
Read, Renee

Emory University School of Medicine
EXTH-27 - YAP/TAZ transcriptional co-activators create therapeutic vulnerability to verteporfin in EGFR mutant glioblastoma
Renee Read
Favorite
Reardon, David

Center for Neuro-Oncology, Dana-Farber Cancer Institute
CTIM-32 - Phase II and biomarker study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma patients
David Reardon
Favorite
LTBK-01 - INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma
David Reardon
Favorite
Riahi Samani, Zahra

University of Pennsylvania
NIMG-21 - Differentiating Tumor Types based on the Peritumoral Microenvironment using ConvolutionalNeural Networks
Zahra Riahi Samani
Favorite
NIMG-45 - Deep learning-based Peritumoral Microstructure mapping in Glioblastomas using free water volume fraction

Zahra Riahi Samani
Favorite
Rockwell, Nathan

Washington University in St. Louis
CBIO-22 - p53 gain-of-function mutations drive sex specific effects on glioma tumorigenesis
Nathan Rockwell
Favorite
Rogers, Leland

GammaWest Cancer Services
CTNI-57 - Low-Risk Meningioma: Outcomes from NRG Oncology/RTOG 0539
Leland Rogers
Favorite
CTNI-58 - A Prospective Trial of Resection and Surgically Targeted Radiation Therapy for Initial or Salvage Treatment of Aggressive Meningioma
Leland Rogers
Favorite
Rooney, Alasdair

Edinburgh Centre for Neuro-Oncology, NHS Lothian, Scotland
INNV-23 - Lifestyle coaching is feasible and improves pilot outcomes in fatigued brain tumour patients: the BT-LIFE (Brain Tumours, Lifestyle Interventions, and Fatigue Evaluation) multi-centre, Phase II RCT.
Alasdair Rooney
Favorite
Rossmeisl, John

Virginia-Maryland College of Veterinary Medicine
EXTH-34 - Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
John Rossmeisl
Favorite
Ruff, Michael

Mayo Clinic
DDRE-18 - Development of EGFRvIII and EGFR Directed Chimeric Antigen Receptor T Cell Therapy for the Treatment of Glioblastoma Multiforme
Michael Ruff
Favorite
Ryan, Katherine

Duke Univeristy Hospital
DDRE-20 - Generation of a High-Affinity EGFR/EGFRvIII-targeted D2C7 CAR-T Cell
Katherine Ryan
Favorite
S
Sabedot, Thais

Henry Ford Health System
EPCO-29 - Epigenomics of the Glioma Longitudinal AnalySiS (GLASS) consortium
Thais Sabedot
Favorite
Sahm, Felix

Heidelberg University
(EANO) Molecular pathology of meningiomas
Felix Sahm
Favorite
Samanic, Claudine

H. Lee Moffitt Cancer Center
EPID-10 - Mitochondrial DNA sequence variation and risk of glioma
Claudine Samanic
Favorite
Sampson, John

Duke University
CTIM-13 - Clinical efficacy of MDNA55, an interleukin-4 receptor targeted immunotherapy, in recurrent GBM delivered by convection enhanced delivery (CED)
John Sampson
Favorite
Sayour, Elias

University of Florida
IMMU-22 - Early release of type I interferon drives brain cancer immunogenicity and response to immunotherapy
Elias Sayour
Favorite
Schaettler, Max

Washington University School of Medicine
IMMU-53 - Characterization of the genomic and immunological diversity of malignant brain tumors through multi-sector analysis
Max Schaettler
Favorite
Schaff, Lauren

Memorial Sloan Kettering Cancer Center
COVD-23 - Planned-use glucarpidase for outpatient high dose methotrexate (HD-MTX) administration in patients with CNS lymphoma (CNSL) during the COVID-19 pandemic
Lauren Schaff
Favorite
Schiapparelli, Paula

Mayo Clinic
CSIG-08 - Targeting ion transport-regulatory kinases as a novel treatment for Glioblastoma
Paula Schiapparelli
Favorite
Schiff, David

University of Virginia
Closing Remarks and Introduction of Roundtables
David Schiff
Favorite
Introduction
David Schiff
Favorite
Introduction
David Schiff
Favorite
Keynote Introduction
David Schiff
Favorite
Keynote Introduction
David Schiff
Favorite
Panel Discussion
David Schiff
Favorite
Top Abstracts and Daniel Orringer, Amy Heimberger and Johanna Joyce Keynotes
David Schiff
Favorite
Top Abstracts and Vinay Prasad Keynote
David Schiff
Favorite
Town Hall: Clinical Trial Designs in 2020 and Beyond
David Schiff
Favorite
Town Hall: COVID-19 and Neuro-Oncology
David Schiff
Favorite
Schreck, Karisa

Johns Hopkins University School of Medicine
DDRE-13 - Deconvoluting mechanisms of resistance to BRAF inhibitors in BRAF V600E human glioma
Karisa Schreck
Favorite
PATH-26 - Integrated molecular and clinical analysis of BRAF-mutated glioma in adults
Karisa Schreck
Favorite
Shamsan, Ghaidan

University of Minnesota
TAMI-28 - Differential migration mechanics and immune responses of glioma subtypes
Ghaidan Shamsan
Favorite
Shelton, Abigail

University of Alabama at Birmingham
DDRE-24 - Acquired resistance to targeted inhibitors in EGFR-driven glioblastoma: Identification of dual kinase targets
Abigail Shelton
Favorite
Shen, Erica

University of Connecticut Health Center
EPID-06 - Quantifying the potential public health impact of varicella zoster virus (VZV) vaccination on glioma incidence
Erica Shen
Favorite
Short, Susan

Leeds Institute of Medical Research at St.James’s, University of Leeds
Introduction to Part 2
Susan Short
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 1
Susan Short
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 2
Susan Short
Favorite
Liquid Biopsy and Molecular Biomarkers, Part 3
Susan Short
Favorite
Panel Discussion
Susan Short
Favorite
Panel Discussion
Susan Short
Favorite
Setting the Stage
Susan Short
Favorite
Welcome
Susan Short
Favorite
CTIM-14 - Pelareorep and granulocyte-macrophage colony-stimulating factor (GM-CSF) with standard chemoradiotherapy/adjuvant temozolomide for glioblastoma multiforme (GBM) patients: ReoGlio phase I trial results
Susan Short
Favorite
Siegelin, Markus

Columbia University Medical Center
TAMI-33 - AURKA Inhibition Reprograms Metabolism and is Synthetically Lethal with Fatty Acid Oxidation Inhibition in Glioblastoma
Markus Siegelin
Favorite
Silverman, Joshua S.

Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
RBIO-01 - Prospective Observational Study to Determine the Immune System Response to Gamma Knife Radiosurgery for Vestibular Schwannomas
Joshua S. Silverman
Favorite
Sloan, Andrew

University Hospitals-Seidman Cancer Center & Case Comprehensive Cancer Center
CTNI-49 - Phase I Study of MGMT-P140K Transfected Hematopoetic Progenitor Cells Combined with TMZ/O6BG Dose Escalation for Newly Diagnosed, unmethylated Glioblastoma: Tolerance and Evidence of Survival Benefit
Andrew Sloan
Favorite
Smilowitz, Henry

Univeristy of Connecticut Health Center
EXTH-03 - iodine Nanoparticle Radiotherapy of Human Breast Cancer Growing in the Brains of Athymic Mice
Henry Smilowitz
Favorite
Solomon, David

University of California San Francisco
PATH-22 - Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor
David Solomon
Favorite
Sponagel, Jasmin

Washington University in St. Louis School of Medicine
TAMI-37 - Sex differences in redox state underlie glutamine dependency in male glioblastoma

Jasmin Sponagel
Favorite
Sridharan, Sreepradha

MD Anderson Cancer Center
DDRE-06 - Cellular stress response in DIPG therapy
Sreepradha Sridharan
Favorite
Srinivasan, Ethan

Duke University School of Medicine
INNV-02 - Radiographic characteristics and steroid usage in laser interstitial thermal therapy versus medical management for biopsy-proven radiation necrosis after stereotactic radiosurgery of brain metastases
Ethan Srinivasan
Favorite
Stackhouse, Christian

University of Alabama at Birmingham
CBIO-12 - The roles of lncRNAs in GBM radiation resistance and tumor recurrence
Christian Stackhouse
Favorite
Strong, Michael

University of Michigan
IMMU-06 - Discerning the Different Bone Marrow Immune Landscapes
Michael Strong
Favorite
Stupp, Roger

Northwestern Feinberg School of Medicine
Panel Discussion
Roger Stupp
Favorite
Sulman, Erik

Department of Radiation Oncology at NYU Grossman School of Medicine
Discussant
Erik Sulman
Favorite
Panel Discussion
Erik Sulman
Favorite
Roundtable: Using Artificial Intelligence in the Clinic Setting
Erik Sulman
Favorite
Sun, Lu

University of California Los Angeles
TAMI-01 - Neoadjuvant PD-1 antibody blockade remodels the immune microenvironment of metastatic brain tumors

Lu Sun
Favorite
Sun, Rosa

University Hospitals Birmingham
INNV-26 - Service reconfiguration into an urgent elective pathway for the management of glioblastoma patients improves outcomes, costs and patient experience and adjunct use: a single centre six year review
Rosa Sun
Favorite
Suva, Mario

Massachusetts General Hospital and Harvard Medical School
Keynote: Harnessing Big Data for Science
Mario Suva
Favorite
Panel Discussion
Mario Suva
Favorite
T
Taylor, Jennie

Department of Neurological Surgery, University of California (UCSF), San Francisco, San Francisco, CA, USA
QOLP-12 - Embedding outpatient palliative care into neuro-oncology clinic – results from a one year pilot
Jennie Taylor
Favorite
Tesileanu, C. Mircea S.

Erasmus MC Cancer Institute
CTNI-23 - IDH1/2wt anaplastic gliomas of the EORTC randomized phase III intergroup CATNON trial: overall survival related to treatment, MGMT status and molecular features of glioblastoma.

C. Mircea S. Tesileanu
Favorite
PATH-11 - Prognostic significance of epigenetic subtypes and CpGs associated with progression to G-CIMP low in the EORTC randomized phase III intergroup CATNON
C. Mircea S. Tesileanu
Favorite
Thawani, Chetna

H. Lee Moffitt Cancer Center & Research Institute
RADT-02 - Clinical Outcomes of Breast Brain Metastases by Subtype following LINAC Based Stereotactic Radiation
Chetna Thawani
Favorite
Theeler, Brett

National Cancer Institute
EXTH-74 - IND-enabling characterization of dual DRD2- and ClpP-targeting agent ONC206 as the next imipridone for clinical neuro-oncology
Brett Theeler
Favorite
Theruvath, Johanna

Stanford University
IMMU-55 - GD2 is a Macrophage Checkpoint Molecule and Combined GD2/CD47 Blockade Results in Synergistic Effects against GD2 positive malignancies
Johanna Theruvath
Favorite
Thokala, Radhika

University of Pennsylvania
IMMU-36 - High affinity chimeric antigen receptor with cross-reactivity to clinically-relevant EGFR mutated proteins
Radhika Thokala
Favorite
Thorsen, Frits

Molecular Imaging Center, Department of Biomedicine, University of Bergen, Bergen, Norway.
TMOD-04 - Inhibition of melanoma brain metastasis by targeting miR146a
Frits Thorsen
Favorite
Tinkle, Christopher

St. Jude Children's Research Hospital
CTNI-27 - First-in-pediatrics phase I study of GDC-0084 (paxalisib), a CNS-penetrant PI3K/mTOR inhibitor, in newly diagnosed diffuse intrinsic pontine glioma (DIPG) or other diffuse midline glioma (DMG)
Christopher Tinkle
Favorite
Troike, Katie

Cleveland Clinic Lerner Research Institute
CBIO-10 - Reduced iron export functions in a cell intrinsic manner to drive glioblastoma growth
Katie Troike
Favorite
Truong, Kevin

University of Connecticut
TMOD-32 - Mutational Analysis of the C11orf95 Domain and Single Cell RNAseq Profile of a Mouse model of Supratentorial Ependymoma
Kevin Truong
Favorite
TMOD-32 - Mutational Analysis of the C11orf95 Domain and Single Cell RNAseq Profile of a Mouse model of Supratentorial Ependymoma
Kevin Truong
Favorite
Tsankova, Nadejda

Icahn School of Medicine at Mount Sinai
EPCO-20 - Relating glioblastoma heterogeneity to human fetal glial development through high resolution single nuclei transcriptomics
Nadejda Tsankova
Favorite
U
Uluc, Kutluay

Oregon Health & Science University
SURG-42 - Safety of intra-arterial chemotherapy with or without osmotic blood brain barrier disruption in treatment of brain tumors
Kutluay Uluc
Favorite
V
Vaghjiani, Nilan

Virginia Commonwealth University School of Medicine
EPID-22 - Characterization of radiation-induced meningiomas in a brain tumor database
Nilan Vaghjiani
Favorite
Vaishnav, Yash

Department of Ophthalmology, The Warren Alpert Medical School of Brown University
RADT-17 - Radiotherapy in the Management of Optic Nerve Sheath Meningiomas: An International Systematic Review and Meta-Analysis of Eighteen Studies
Yash Vaishnav
Favorite
van der Meer, Pim

Leiden University Medical Center
NCOG-45 - First-line antiepileptic drug treatment in glioma patients with epilepsy: levetiracetam versus valproic acid
Pim van der Meer
Favorite
Venneti, Sriram

University of Michigan Medical School
TAMI-42 - H3K27M mutant gliomas hijack a conserved and critical metabolic pathway used by IDH1 mutant gliomas to maintain their preferred epigenetic state
Sriram Venneti
Favorite
Viswanath, Pavithra

Department of Radiology and Biomedical Imaging, University of California San Francisco
TAMI-08 - A tale of two telomere maintenance mechanisms: TERT expression and the ALT pathway induce unique MRS-detectable metabolic reprogramming in low-grade gliomas
Pavithra Viswanath
Favorite
Vogelbaum, Michael

H Lee Moffitt Cancer Center
Panel Discussion
Michael Vogelbaum
Favorite
Voisin, Mathew

University of Toronto
IBTA Survey: Brain tumours and COVID-19: the patient and caregiver experience
Mathew Voisin
Favorite
Panel Discussion
Mathew Voisin
Favorite
von Roemeling, Christina

University of Florida
EXTH-32 - Targeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma
Christina von Roemeling
Favorite
W
Walsh, Kyle

Duke University Medical Center
BIOM-17 - BRAF mutation is an early event in the evolution of a subset of glioblastomas and is associated with increased PD-L1 expression
Kyle Walsh
Favorite
BIOM-50 - Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma
Kyle Walsh
Favorite
Wang, Jacqueline

Case Western Reserve University School of Medicine
EPID-02 - Stereotactic radiosurgery and chemotherapy treatment patterns in breast cancer brain metastases
Jacqueline Wang
Favorite
Watson, Adrienne

Recombinetics
EXTH-08 - Minipig models of Neurofibromatosis Type 1 for therapeutic development
Adrienne Watson
Favorite
Weber, Shannon

Medical University of South Carolina
CSIG-02 - R-Ras Subfamily Proteins Elicit Distinct Physiologic Effects and Phosphoproteome Alterations in Neurofibromin-Null MPNST Cells
Shannon Weber
Favorite
Wechsler-Reya, Robert

Sanford Burnham Prebys Medical Discovery Institute
Introduction
Robert Wechsler-Reya
Favorite
Wechsler-Reya, Robert

Sanford Burnham Prebys Medical Discovery Institute
Panel Discussion
Robert Wechsler-Reya
Favorite
Roundtable: What's New in Pediatric Neuro-Oncology?
Robert Wechsler-Reya
Favorite
Wee, Chan Woo

SMU-SNU Boramae Medical Center
RADT-35 - Postoperative radiotherapy for WHO grade II–III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01)
Chan Woo Wee
Favorite
Wefel, Jeffrey

The University of Texas MD Anderson Cancer Center
CTNI-50 - Neurocognitive function (NCF) of the Photon Cohort in NRG-BN001
Jeffrey Wefel
Favorite
CTNI-51 - Neurocognitive function (NCF) outcomes of RTOG Foundation 3508: A Phase 3 trial of ABT-414 with concurrent chemoradiation and adjuvant temozolomide in patients with EGFR-amplified newly diagnosed GBM
Jeffrey Wefel
Favorite
Weiss, Tobias

Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich
IMMU-07 - Tumor stroma–targeting antibody-cytokine conjugates to convert the immunologically cold glioma microenvironment into a hot one
Tobias Weiss
Favorite
Wen, Patrick

Dana-Farber Cancer Institute
Panel Discussion
Patrick Wen
Favorite
CTNI-12 - Preliminary results of the abemaciclib arm in the Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): a phase II platform trial using Bayesian adaptive randomization.
Patrick Wen
Favorite
Wiencke, John

Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, CA, USA
BIOM-13 - DNA methylation marks glucocorticoid pathway response in dexamethasone-treated brain tumor patients
John Wiencke
Favorite
WONG, Gabriel Chun-Hei

The Chinese University of Hong Kong
PATH-32 - Clinical and mutational profiles of adult medulloblastoma groups
Gabriel Chun-Hei WONG
Favorite
WONG, Queenie Hoi-Wing

The Chinese University of Hong Kong
PATH-23 - Genomic landscape of IDH-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication
Queenie Hoi-Wing WONG
Favorite
Wright, Karen

Dana-Farber Cancer Institute/Boston Children's Hospital
CTNI-19 - Phase I trial of DAY101 in pediatric patients with radiographically recurrent or progressive low-grade glioma (LGG)
Karen Wright
Favorite
Würdinger, Thomas

Vrije Universiteit Amsterdam
Isolation and Analysis of Tumour-Educated Platelets in Patients with Glioma
Thomas Würdinger
Favorite
Y
Yahn, Stephanie

Translational Genomics Research Institute
EPCO-18 - Multi-modal and multi-tissue profiling of GBM patients treated with CAR T cell therapy to elucidate molecular mechanisms of variation in treatment response
Stephanie Yahn
Favorite
Yegorov, Oleg

University of Florida
CTIM-29 - Crucial application of single cell gene expression for monitoring changes in glioblastoma patients with sustained radiographic response to CMV pp65-LAMP RNA-pulsed dendritic cell-based vaccines
Oleg Yegorov
Favorite
Yim, Eunji

University of Michigan
EPID-27 - The vanishing tumor phenomenon in the diagnosis of primary CNS lymphoma
Eunji Yim
Favorite
Young, Jacob

University of California, San Francisco
SURG-25 - Effect of Ventricular Entry During Glioblastoma Resection on Patient Outcomes
Jacob Young
Favorite
Yu, Yao

Memorial Sloan Kettering
PATH-12 - Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence and reduced survival in initially low grade IDH-mutant gliomas
Yao Yu
Favorite
Z
Zadeh, Gelareh

Princess Margaret Cancer Center, University Health Network
Friends of SNO
Gelareh Zadeh
Favorite
Introduction
Gelareh Zadeh
Favorite
Panel Discussion
Gelareh Zadeh
Favorite
Presidential Address
Gelareh Zadeh
Favorite
Town Hall: Clinical Trial Designs in 2020 and Beyond
Gelareh Zadeh
Favorite
Welcome
Gelareh Zadeh
Favorite
Welcome and Introduction
Gelareh Zadeh
Favorite
What's New at SNO
Gelareh Zadeh
Favorite
LTBK-04 - Phase 2 multicenter study of the oncolytic adenovirus DNX-2401 (tasadenoturev) in combination with pembrolizumab for recurrent glioblastoma; CAPTIVE Study (KEYNOTE-192)
Gelareh Zadeh
Favorite
Zarrella, Giuliana

Massachusetts General Hospital - Boston, MA
NCOG-70 - Reliability and validity of a new self-report index of cognitive concerns in brain tumor patients
Giuliana Zarrella
Favorite
Zhang, Daniel

University of Pennsylvania
IMMU-30 - Dissecting the dynamic responses of glioblastoma to CAR T cell therapy using patient-derived tumor organoids and single-cell multi-omics analyses
Daniel Zhang
Favorite
Zhu, Jay-Jiguang

McGovern Medical School, The University of Texas Health Science Ctr at Houston
CTNI-77 - EF-19, a post-approval registry study of Tumor Treating Fields (TTFields) in recurrent glioblastoma (rGBM)
Jay-Jiguang Zhu
Favorite
Zhu, Ping

McGovern Medical School, The University of Texas Health Science Ctr at Houston
EPID-34 - The detrimental effect of biopsy preceding resection in surgically accessible Glioblastomas: Results from the National Cancer Database
Ping Zhu
Favorite
Zuccato, Jeffrey

University of Toronto
EPCO-01 - Lung adenocarcinoma brain metastasis prediction, prevention, and non-invasive diagnosis using methylation signatures within tissue and circulating tumour DNA
Jeffrey Zuccato
Favorite